• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义前列腺癌的显著与非显著的阈值。

Defining the threshold for significant versus insignificant prostate cancer.

机构信息

Department of Laboratory Medicine and Pathobiology, University of Toronto, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada.

出版信息

Nat Rev Urol. 2013 Aug;10(8):473-82. doi: 10.1038/nrurol.2013.112. Epub 2013 May 28.

DOI:10.1038/nrurol.2013.112
PMID:23712205
Abstract

Autopsy studies have shown the presence of a large reservoir of latent prostate cancers in adult men. Serum PSA testing of asymptomatic men leads to the detection of a proportion of these latent prostate cancers. The unequivocal demonstration of a substantial (30-50%) risk of overdiagnosis by the two largest randomized population-based screening trials has led to a growing awareness of this unwanted effect. Unsurprisingly, active surveillance is now becoming the favoured strategy for deferring active treatment in men diagnosed with low-risk prostate cancer and reducing their risk of overtreatment. Almost all eligibility criteria for active surveillance refer to a strict pathological definition of insignificant prostate cancer, based on two landmark studies published about 20 years ago. However, current epidemiological data suggest that this original pathological definition of insignificant prostate cancer is too restrictive. In addition, the International Society of Urological Pathology (ISUP) 2005 modification to the Gleason grading system might have resulted in a marked upgrading of biopsy-diagnosed prostate cancers, reducing the number of men eligible for active surveillance. An updated definition of insignificant prostate cancer should reflect the optimal trade-off between reducing the risk of underestimating a significant prostate cancer and including as many men as possible in active surveillance programmes.

摘要

尸检研究表明,成年男性的前列腺中存在大量潜伏的前列腺癌。对无症状男性进行血清 PSA 检测会发现其中一部分潜伏的前列腺癌。两项最大的随机人群筛查试验明确证明了过度诊断的风险相当大(30-50%),这导致人们越来越意识到这种不良影响。不出所料,主动监测现在成为诊断为低危前列腺癌的男性推迟主动治疗并降低过度治疗风险的首选策略。几乎所有主动监测的入选标准都指的是基于大约 20 年前发表的两项具有里程碑意义的研究的严格的前列腺癌无意义的病理定义。然而,目前的流行病学数据表明,最初的前列腺癌无意义的病理定义过于严格。此外,国际泌尿病理学会(ISUP)2005 年对格里森分级系统的修改可能导致活检诊断的前列腺癌明显升级,从而减少了适合主动监测的男性人数。前列腺癌无意义的新定义应反映在降低低估有意义的前列腺癌的风险和尽可能多地将男性纳入主动监测计划之间的最佳权衡。

相似文献

1
Defining the threshold for significant versus insignificant prostate cancer.定义前列腺癌的显著与非显著的阈值。
Nat Rev Urol. 2013 Aug;10(8):473-82. doi: 10.1038/nrurol.2013.112. Epub 2013 May 28.
2
An evidence review of active surveillance in men with localized prostate cancer.局限性前列腺癌男性患者主动监测的证据综述。
Evid Rep Technol Assess (Full Rep). 2011 Dec(204):1-341.
3
Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing.主动监测是前列腺特异性抗原检测诊断前列腺癌患者的一种适当的管理策略。
J Urol. 2015 Sep;194(3):680-4. doi: 10.1016/j.juro.2015.01.089. Epub 2015 Jan 28.
4
The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer.前列腺癌干预与观察试验:退伍军人事务部/美国国立癌症研究所/医疗保健研究与质量局合作研究项目#407(PIVOT):一项比较根治性前列腺切除术与对临床局限性前列腺癌男性进行观察等待的随机对照试验的设计和基线结果
J Natl Cancer Inst Monogr. 2012 Dec;2012(45):184-90. doi: 10.1093/jncimonographs/lgs041.
5
Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.基于人群的研究:预测前列腺癌 Gleason6 评分患者主动监测不良病理的因素。
J Urol. 2014 Feb;191(2):350-7. doi: 10.1016/j.juro.2013.09.034. Epub 2013 Sep 23.
6
Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients.前列腺癌主动监测的随访:严格遵守方案对不符合 PRIAS 标准的患者仍然重要。
Eur Urol Oncol. 2019 Sep;2(5):483-489. doi: 10.1016/j.euo.2019.01.010. Epub 2019 Feb 10.
7
Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.活检核心特征是预测低级别前列腺癌患者不良病理的不良指标。
J Urol. 2018 Apr;199(4):961-968. doi: 10.1016/j.juro.2017.10.010. Epub 2017 Oct 10.
8
Gleason 6 Prostate Cancer: Translating Biology into Population Health.Gleason 6级前列腺癌:将生物学转化为人群健康
J Urol. 2015 Sep;194(3):626-34. doi: 10.1016/j.juro.2015.01.126. Epub 2015 Apr 4.
9
Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3 + 4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance.低危 Gleason 评分 6 与中危 Gleason 评分 3+4 前列腺癌的病理和肿瘤学结局比较:主动监测的考虑因素。
J Urol. 2018 May;199(5):1188-1195. doi: 10.1016/j.juro.2017.11.116. Epub 2017 Dec 7.
10
Gleason inflation 1998-2011: a registry study of 97,168 men.格里森评分膨胀 1998-2011:97168 名男性的注册研究。
BJU Int. 2015 Feb;115(2):248-55. doi: 10.1111/bju.12671.

引用本文的文献

1
Lesional volume in the prediction of clinically significant prostate cancer.病变体积在预测具有临床意义的前列腺癌中的作用
World J Surg Oncol. 2025 Jul 19;23(1):290. doi: 10.1186/s12957-025-03905-z.
2
Secular Trends in the Prevalence of Total and Latent Prostate Cancer over Half a Century According to Consecutive Autopsy Cases in a Japanese community: The Hisayama Study.根据日本一个社区连续尸检病例得出的半个世纪以来前列腺癌总体患病率和潜伏性前列腺癌患病率的长期趋势:久山研究
Eur Urol Open Sci. 2025 Jun 19;78:9-15. doi: 10.1016/j.euros.2025.05.013. eCollection 2025 Aug.
3
Evaluation of Proclarix in the diagnostic work-up of prostate cancer.

本文引用的文献

1
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.整合基因组分析揭示了早发性前列腺癌中雄激素驱动的体细胞改变图谱。
Cancer Cell. 2013 Feb 11;23(2):159-70. doi: 10.1016/j.ccr.2013.01.002.
2
Standardization of Gleason grading among 337 European pathologists.337 位欧洲病理学家之间的 Gleason 分级标准化。
Histopathology. 2013 Jan;62(2):247-56. doi: 10.1111/his.12008.
3
Clonal progression of prostate cancers from Gleason grade 3 to grade 4.前列腺癌从格里森 3 级到 4 级的克隆进展。
Proclarix在前列腺癌诊断检查中的评估。
BJUI Compass. 2023 Sep 29;5(2):297-303. doi: 10.1002/bco2.293. eCollection 2024 Mar.
4
Nanoribbon Biosensor-Based Detection of microRNA Markers of Prostate Cancer.基于纳米带生物传感器的前列腺癌 microRNA 标志物检测。
Sensors (Basel). 2023 Aug 30;23(17):7527. doi: 10.3390/s23177527.
5
An Apparent Diffusion Coefficient-Based Machine Learning Model Can Improve Prostate Cancer Detection in the Grey Area of the Prostate Imaging Reporting and Data System Category 3: A Single-Centre Experience.基于表观扩散系数的机器学习模型可改善前列腺影像报告和数据系统3类灰色区域中的前列腺癌检测:单中心经验
Cancers (Basel). 2023 Jun 30;15(13):3438. doi: 10.3390/cancers15133438.
6
Single-Setting 3D MRI/US-Guided Frozen Sectioning and Cryoablation of the Index Lesion: Mid-Term Oncologic and Functional Outcomes from a Pilot Study.单场景3D MRI/超声引导下对索引病灶进行冷冻切片检查及冷冻消融:一项前瞻性研究的中期肿瘤学和功能学结果
J Pers Med. 2023 Jun 10;13(6):978. doi: 10.3390/jpm13060978.
7
microRNA-205 in prostate cancer: Overview to clinical translation.微小 RNA-205 在前列腺癌中的作用:从临床前研究到临床转化。
Biochim Biophys Acta Rev Cancer. 2022 Nov;1877(6):188809. doi: 10.1016/j.bbcan.2022.188809. Epub 2022 Oct 1.
8
Comparison of malignancy and spatial distribution between latent and clinical prostate cancer: an 8-year biopsy study.潜伏性与临床型前列腺癌恶性程度和空间分布的比较:一项 8 年的活检研究。
Eur J Med Res. 2022 Sep 10;27(1):175. doi: 10.1186/s40001-022-00801-0.
9
Hippo pathway monomerizes STAT3 to regulate prostate cancer growth.Hippo 通路单体化 STAT3 以调节前列腺癌生长。
Cancer Sci. 2022 Aug;113(8):2753-2762. doi: 10.1111/cas.15463. Epub 2022 Jun 28.
10
The importance of personalized medicine in urological cancers.个性化医疗在泌尿生殖系统癌症中的重要性。
J Diabetes Metab Disord. 2021 Jun 29;21(1):841-852. doi: 10.1007/s40200-021-00824-0. eCollection 2022 Jun.
Cancer Res. 2013 Feb 1;73(3):1050-5. doi: 10.1158/0008-5472.CAN-12-2799. Epub 2012 Nov 30.
4
Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database.对于中危前列腺癌患者,延迟行根治性前列腺切除术与生化复发相关:来自 SEARCH 数据库的主动监测的可能影响。
Prostate. 2013 Mar;73(4):409-17. doi: 10.1002/pros.22582. Epub 2012 Sep 19.
5
Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.MR 成像在评估临床低危前列腺癌中的性能特征:一项前瞻性研究。
Radiology. 2012 Nov;265(2):478-87. doi: 10.1148/radiol.12120041. Epub 2012 Sep 5.
6
Active surveillance for low-risk prostate cancer.主动监测低危前列腺癌。
Crit Rev Oncol Hematol. 2013 Mar;85(3):295-302. doi: 10.1016/j.critrevonc.2012.07.005. Epub 2012 Aug 9.
7
Radical prostatectomy versus observation for localized prostate cancer.根治性前列腺切除术与观察等待治疗局限性前列腺癌的比较。
N Engl J Med. 2012 Jul 19;367(3):203-13. doi: 10.1056/NEJMoa1113162.
8
Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: a multicenter study.符合高度选择性标准的主动监测患者的根治性前列腺切除术标本的病理发现:一项多中心研究。
Urology. 2012 Sep;80(3):656-60. doi: 10.1016/j.urology.2012.04.051. Epub 2012 Jul 7.
9
Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.2005 年国际泌尿病理学会改良 Gleason 分级系统对前列腺癌临床结局的影响。
Am J Surg Pathol. 2012 Jun;36(6):838-43. doi: 10.1097/PAS.0b013e3182486faf.
10
Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?前列腺 Gleason 评分(GS)≤6 的腺癌是否有转移到淋巴结的潜力?
Am J Surg Pathol. 2012 Sep;36(9):1346-52. doi: 10.1097/PAS.0b013e3182556dcd.